<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01984957</url>
  </required_header>
  <id_info>
    <org_study_id>P110401</org_study_id>
    <nct_id>NCT01984957</nct_id>
  </id_info>
  <brief_title>Differential Study of Muscle Transcriptome</brief_title>
  <acronym>TRANE</acronym>
  <official_title>Differential Study of Muscle Transcriptome in Patients With Neuromuscular Disease and Control Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Direction Générale de l'Offre de Soins</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To isolate biomarkers of ALS in muscle
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At present, there is no validated biological diagnostic marker for amyotrophic lateral
      sclerosis (ALS). The main objective of the study is to isolate a set of genes that are
      specifically dysregulated in muscle from ALS patients.

      Gene profiling in muscle will be compared between ALS patients and patients with other motor
      neuron diseases (SMA and SBMA)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gene expression levels</measure>
    <time_frame>day 1</time_frame>
    <description>Gene expression levels in muscle as determined By microarrays (transcriptome analysis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle denervation</measure>
    <time_frame>day 1</time_frame>
    <description>Severity of muscle denervation as determined by histological analysis of muscle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional evaluation</measure>
    <time_frame>day 1</time_frame>
    <description>ALSFRS-R, Manual Muscle Testing and Slow Vital Capacity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>ALS</condition>
  <condition>SMA</condition>
  <condition>SBMA</condition>
  <arm_group>
    <arm_group_label>disease (ALS, SMA or SBMA)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>muscle biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Muscle biopsy</intervention_name>
    <description>open muscular biopsy of the deltoid under local anaesthesia</description>
    <arm_group_label>disease (ALS, SMA or SBMA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :

        - Patient with ALS, SMA, or SBMA

        Exclusion criteria :

          -  Indication against biopsy (allergy to anesthetics local haemostasis disorders)

          -  Treatments that can affect muscle metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Francois Pradat, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'évaluation Thérapeutique, Dr LACOMBLEZ</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2013</study_first_submitted>
  <study_first_submitted_qc>November 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2013</study_first_posted>
  <last_update_submitted>March 20, 2015</last_update_submitted>
  <last_update_submitted_qc>March 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ALS</keyword>
  <keyword>Motor neuron diseases</keyword>
  <keyword>Transcriptome</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

